thiazoles has been researched along with 10074-g5 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Follis, AV; Hammoudeh, DI; Metallo, SJ; Prochownik, EV; Wang, H | 1 |
Beumer, JH; Clausen, DM; Egorin, MJ; Eiseman, JL; Guo, J; Lazo, JS; Parise, RA; Prochownik, EV | 1 |
Bister, K; Hart, JR; Hartl, M; Janda, KD; Raffeiner, P; Röck, R; Schraffl, A; Stefan, E; Vogt, PK | 1 |
3 other study(ies) available for thiazoles and 10074-g5
Article | Year |
---|---|
Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules.
Topics: Amino Acid Sequence; Binding Sites; Humans; Molecular Sequence Data; Mutation; Oxadiazoles; Protein Binding; Protein Conformation; Protein Denaturation; Protein Multimerization; Proto-Oncogene Proteins c-myc; Thiazoles | 2008 |
In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization.
Topics: Animal Structures; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blood Proteins; Cell Line, Tumor; Cell Survival; Doxorubicin; Feces; Female; Glucuronates; Glucuronidase; HL-60 Cells; Humans; Inhibitory Concentration 50; Liver; Mice; Mice, SCID; Neoplasms; Oxadiazoles; Plasma; Protein Binding; Protein Multimerization; Proto-Oncogene Proteins c-myc; Tandem Mass Spectrometry; Thiazoles; Treatment Outcome; Urine; Xenograft Model Antitumor Assays | 2010 |
In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Cell Proliferation; HEK293 Cells; Humans; Luciferases, Renilla; Neoplasms; Oxadiazoles; Protein Binding; Protein Multimerization; Proto-Oncogene Proteins c-myc; Pyridines; Repressor Proteins; Thiazoles | 2014 |